nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—Swelling—Zoledronate—osteoporosis	0.00654	0.00654	CcSEcCtD
Mepivacaine—Paraesthesia—Calcium Acetate—osteoporosis	0.00653	0.00653	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Pamidronate—osteoporosis	0.00652	0.00652	CcSEcCtD
Mepivacaine—Swelling—Conjugated Estrogens—osteoporosis	0.00629	0.00629	CcSEcCtD
Mepivacaine—Drowsiness—Calcitriol—osteoporosis	0.00608	0.00608	CcSEcCtD
Mepivacaine—Sweating—Raloxifene—osteoporosis	0.00601	0.00601	CcSEcCtD
Mepivacaine—Sweating—Ibandronate—osteoporosis	0.00595	0.00595	CcSEcCtD
Mepivacaine—Urinary incontinence—Estradiol—osteoporosis	0.00591	0.00591	CcSEcCtD
Mepivacaine—Erythema—Etidronic acid—osteoporosis	0.00585	0.00585	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Conjugated Estrogens—osteoporosis	0.00574	0.00574	CcSEcCtD
Mepivacaine—Hypersensitivity—Calcium Acetate—osteoporosis	0.00536	0.00536	CcSEcCtD
Mepivacaine—Angioedema—Etidronic acid—osteoporosis	0.00535	0.00535	CcSEcCtD
Mepivacaine—Sweating increased—Pamidronate—osteoporosis	0.00532	0.00532	CcSEcCtD
Mepivacaine—Asthenia—Calcium Acetate—osteoporosis	0.00522	0.00522	CcSEcCtD
Mepivacaine—Pruritus—Calcium Acetate—osteoporosis	0.00515	0.00515	CcSEcCtD
Mepivacaine—Erythema—Estropipate—osteoporosis	0.00506	0.00506	CcSEcCtD
Mepivacaine—Swelling—Estradiol—osteoporosis	0.00504	0.00504	CcSEcCtD
Mepivacaine—Chills—Ibandronate—osteoporosis	0.005	0.005	CcSEcCtD
Mepivacaine—Erythema—Alendronate—osteoporosis	0.00498	0.00498	CcSEcCtD
Mepivacaine—Tension—Estropipate—osteoporosis	0.00497	0.00497	CcSEcCtD
Mepivacaine—Nervousness—Estropipate—osteoporosis	0.00492	0.00492	CcSEcCtD
Mepivacaine—Back pain—Estropipate—osteoporosis	0.0049	0.0049	CcSEcCtD
Mepivacaine—Sweating increased—Zoledronate—osteoporosis	0.00486	0.00486	CcSEcCtD
Mepivacaine—Erythema—Ibandronate—osteoporosis	0.00485	0.00485	CcSEcCtD
Mepivacaine—Dizziness—Calcium Acetate—osteoporosis	0.00481	0.00481	CcSEcCtD
Mepivacaine—Erythema—Calcitriol—osteoporosis	0.00475	0.00475	CcSEcCtD
Mepivacaine—Back pain—Ibandronate—osteoporosis	0.00469	0.00469	CcSEcCtD
Mepivacaine—Sweating increased—Conjugated Estrogens—osteoporosis	0.00468	0.00468	CcSEcCtD
Mepivacaine—Angioedema—Estropipate—osteoporosis	0.00462	0.00462	CcSEcCtD
Mepivacaine—Vomiting—Calcium Acetate—osteoporosis	0.00462	0.00462	CcSEcCtD
Mepivacaine—Asthenia—Ergocalciferol—osteoporosis	0.00461	0.00461	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Estradiol—osteoporosis	0.00459	0.00459	CcSEcCtD
Mepivacaine—Angioedema—Alendronate—osteoporosis	0.00455	0.00455	CcSEcCtD
Mepivacaine—Angioedema—Ibandronate—osteoporosis	0.00443	0.00443	CcSEcCtD
Mepivacaine—Syncope—Raloxifene—osteoporosis	0.0044	0.0044	CcSEcCtD
Mepivacaine—Agitation—Calcitriol—osteoporosis	0.00437	0.00437	CcSEcCtD
Mepivacaine—Nausea—Calcium Acetate—osteoporosis	0.00432	0.00432	CcSEcCtD
Mepivacaine—Loss of consciousness—Raloxifene—osteoporosis	0.00431	0.00431	CcSEcCtD
Mepivacaine—Anxiety—Estropipate—osteoporosis	0.00429	0.00429	CcSEcCtD
Mepivacaine—Paraesthesia—Etidronic acid—osteoporosis	0.00429	0.00429	CcSEcCtD
Mepivacaine—Tinnitus—Risedronate—osteoporosis	0.00428	0.00428	CcSEcCtD
Mepivacaine—Hypertension—Ibandronate—osteoporosis	0.00419	0.00419	CcSEcCtD
Mepivacaine—Anaphylactic shock—Estropipate—osteoporosis	0.00413	0.00413	CcSEcCtD
Mepivacaine—Oedema—Estropipate—osteoporosis	0.00413	0.00413	CcSEcCtD
Mepivacaine—Anxiety—Ibandronate—osteoporosis	0.00412	0.00412	CcSEcCtD
Mepivacaine—Convulsion—Calcitriol—osteoporosis	0.00412	0.00412	CcSEcCtD
Mepivacaine—Hypertension—Calcitriol—osteoporosis	0.0041	0.0041	CcSEcCtD
Mepivacaine—Bradycardia—Zoledronate—osteoporosis	0.00406	0.00406	CcSEcCtD
Mepivacaine—Anxiety—Calcitriol—osteoporosis	0.00403	0.00403	CcSEcCtD
Mepivacaine—Back pain—Ethinyl Estradiol—osteoporosis	0.00397	0.00397	CcSEcCtD
Mepivacaine—Anaphylactic shock—Ibandronate—osteoporosis	0.00396	0.00396	CcSEcCtD
Mepivacaine—Shock—Raloxifene—osteoporosis	0.00394	0.00394	CcSEcCtD
Mepivacaine—Chills—Pamidronate—osteoporosis	0.00392	0.00392	CcSEcCtD
Mepivacaine—Shock—Ibandronate—osteoporosis	0.0039	0.0039	CcSEcCtD
Mepivacaine—Anaphylactic shock—Calcitriol—osteoporosis	0.00388	0.00388	CcSEcCtD
Mepivacaine—Back pain—Risedronate—osteoporosis	0.00387	0.00387	CcSEcCtD
Mepivacaine—Hyperhidrosis—Raloxifene—osteoporosis	0.00387	0.00387	CcSEcCtD
Mepivacaine—Hyperhidrosis—Ibandronate—osteoporosis	0.00383	0.00383	CcSEcCtD
Mepivacaine—Nausea—Ergocalciferol—osteoporosis	0.00382	0.00382	CcSEcCtD
Mepivacaine—Erythema—Pamidronate—osteoporosis	0.0038	0.0038	CcSEcCtD
Mepivacaine—Urticaria—Etidronic acid—osteoporosis	0.00379	0.00379	CcSEcCtD
Mepivacaine—Angioedema—Ethinyl Estradiol—osteoporosis	0.00375	0.00375	CcSEcCtD
Mepivacaine—Sweating increased—Estradiol—osteoporosis	0.00374	0.00374	CcSEcCtD
Mepivacaine—Tension—Pamidronate—osteoporosis	0.00373	0.00373	CcSEcCtD
Mepivacaine—Paraesthesia—Estropipate—osteoporosis	0.00371	0.00371	CcSEcCtD
Mepivacaine—Nervousness—Pamidronate—osteoporosis	0.00369	0.00369	CcSEcCtD
Mepivacaine—Back pain—Pamidronate—osteoporosis	0.00368	0.00368	CcSEcCtD
Mepivacaine—Somnolence—Estropipate—osteoporosis	0.00367	0.00367	CcSEcCtD
Mepivacaine—Angioedema—Risedronate—osteoporosis	0.00365	0.00365	CcSEcCtD
Mepivacaine—Syncope—Risedronate—osteoporosis	0.00359	0.00359	CcSEcCtD
Mepivacaine—Chills—Zoledronate—osteoporosis	0.00358	0.00358	CcSEcCtD
Mepivacaine—Paraesthesia—Ibandronate—osteoporosis	0.00356	0.00356	CcSEcCtD
Mepivacaine—Hypersensitivity—Etidronic acid—osteoporosis	0.00352	0.00352	CcSEcCtD
Mepivacaine—Loss of consciousness—Risedronate—osteoporosis	0.00352	0.00352	CcSEcCtD
Mepivacaine—Agitation—Pamidronate—osteoporosis	0.00349	0.00349	CcSEcCtD
Mepivacaine—Anxiety—Ethinyl Estradiol—osteoporosis	0.00348	0.00348	CcSEcCtD
Mepivacaine—Angioedema—Pamidronate—osteoporosis	0.00347	0.00347	CcSEcCtD
Mepivacaine—Erythema—Zoledronate—osteoporosis	0.00347	0.00347	CcSEcCtD
Mepivacaine—Hypertension—Risedronate—osteoporosis	0.00345	0.00345	CcSEcCtD
Mepivacaine—Somnolence—Calcitriol—osteoporosis	0.00345	0.00345	CcSEcCtD
Mepivacaine—Syncope—Pamidronate—osteoporosis	0.00341	0.00341	CcSEcCtD
Mepivacaine—Anxiety—Risedronate—osteoporosis	0.00339	0.00339	CcSEcCtD
Mepivacaine—Pruritus—Etidronic acid—osteoporosis	0.00338	0.00338	CcSEcCtD
Mepivacaine—Back pain—Zoledronate—osteoporosis	0.00336	0.00336	CcSEcCtD
Mepivacaine—Oedema—Ethinyl Estradiol—osteoporosis	0.00335	0.00335	CcSEcCtD
Mepivacaine—Erythema—Conjugated Estrogens—osteoporosis	0.00334	0.00334	CcSEcCtD
Mepivacaine—Loss of consciousness—Pamidronate—osteoporosis	0.00334	0.00334	CcSEcCtD
Mepivacaine—Convulsion—Pamidronate—osteoporosis	0.00329	0.00329	CcSEcCtD
Mepivacaine—Hypertension—Pamidronate—osteoporosis	0.00328	0.00328	CcSEcCtD
Mepivacaine—Tension—Conjugated Estrogens—osteoporosis	0.00328	0.00328	CcSEcCtD
Mepivacaine—Urticaria—Estropipate—osteoporosis	0.00328	0.00328	CcSEcCtD
Mepivacaine—Vision blurred—Zoledronate—osteoporosis	0.00327	0.00327	CcSEcCtD
Mepivacaine—Body temperature increased—Estropipate—osteoporosis	0.00327	0.00327	CcSEcCtD
Mepivacaine—Tremor—Zoledronate—osteoporosis	0.00325	0.00325	CcSEcCtD
Mepivacaine—Nervousness—Conjugated Estrogens—osteoporosis	0.00325	0.00325	CcSEcCtD
Mepivacaine—Back pain—Conjugated Estrogens—osteoporosis	0.00323	0.00323	CcSEcCtD
Mepivacaine—Urticaria—Alendronate—osteoporosis	0.00323	0.00323	CcSEcCtD
Mepivacaine—Anxiety—Pamidronate—osteoporosis	0.00323	0.00323	CcSEcCtD
Mepivacaine—Body temperature increased—Alendronate—osteoporosis	0.00322	0.00322	CcSEcCtD
Mepivacaine—Shock—Risedronate—osteoporosis	0.00321	0.00321	CcSEcCtD
Mepivacaine—Agitation—Zoledronate—osteoporosis	0.00319	0.00319	CcSEcCtD
Mepivacaine—Angioedema—Zoledronate—osteoporosis	0.00317	0.00317	CcSEcCtD
Mepivacaine—Body temperature increased—Raloxifene—osteoporosis	0.00316	0.00316	CcSEcCtD
Mepivacaine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00315	0.00315	CcSEcCtD
Mepivacaine—Urticaria—Ibandronate—osteoporosis	0.00315	0.00315	CcSEcCtD
Mepivacaine—Body temperature increased—Ibandronate—osteoporosis	0.00313	0.00313	CcSEcCtD
Mepivacaine—Syncope—Zoledronate—osteoporosis	0.00311	0.00311	CcSEcCtD
Mepivacaine—Oedema—Pamidronate—osteoporosis	0.0031	0.0031	CcSEcCtD
Mepivacaine—Anaphylactic shock—Pamidronate—osteoporosis	0.0031	0.0031	CcSEcCtD
Mepivacaine—Urticaria—Calcitriol—osteoporosis	0.00308	0.00308	CcSEcCtD
Mepivacaine—Body temperature increased—Calcitriol—osteoporosis	0.00307	0.00307	CcSEcCtD
Mepivacaine—Angioedema—Conjugated Estrogens—osteoporosis	0.00306	0.00306	CcSEcCtD
Mepivacaine—Shock—Pamidronate—osteoporosis	0.00305	0.00305	CcSEcCtD
Mepivacaine—Loss of consciousness—Zoledronate—osteoporosis	0.00305	0.00305	CcSEcCtD
Mepivacaine—Hypersensitivity—Estropipate—osteoporosis	0.00304	0.00304	CcSEcCtD
Mepivacaine—Vomiting—Etidronic acid—osteoporosis	0.00304	0.00304	CcSEcCtD
Mepivacaine—Tachycardia—Pamidronate—osteoporosis	0.00303	0.00303	CcSEcCtD
Mepivacaine—Convulsion—Zoledronate—osteoporosis	0.00301	0.00301	CcSEcCtD
Mepivacaine—Hyperhidrosis—Pamidronate—osteoporosis	0.003	0.003	CcSEcCtD
Mepivacaine—Syncope—Conjugated Estrogens—osteoporosis	0.003	0.003	CcSEcCtD
Mepivacaine—Hypertension—Zoledronate—osteoporosis	0.003	0.003	CcSEcCtD
Mepivacaine—Hypersensitivity—Alendronate—osteoporosis	0.003	0.003	CcSEcCtD
Mepivacaine—Headache—Etidronic acid—osteoporosis	0.00299	0.00299	CcSEcCtD
Mepivacaine—Asthenia—Estropipate—osteoporosis	0.00296	0.00296	CcSEcCtD
Mepivacaine—Anxiety—Zoledronate—osteoporosis	0.00295	0.00295	CcSEcCtD
Mepivacaine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00294	0.00294	CcSEcCtD
Mepivacaine—Paraesthesia—Risedronate—osteoporosis	0.00293	0.00293	CcSEcCtD
Mepivacaine—Pruritus—Estropipate—osteoporosis	0.00292	0.00292	CcSEcCtD
Mepivacaine—Asthenia—Alendronate—osteoporosis	0.00292	0.00292	CcSEcCtD
Mepivacaine—Hypersensitivity—Ibandronate—osteoporosis	0.00292	0.00292	CcSEcCtD
Mepivacaine—Hypotension—Pamidronate—osteoporosis	0.0029	0.0029	CcSEcCtD
Mepivacaine—Convulsion—Conjugated Estrogens—osteoporosis	0.0029	0.0029	CcSEcCtD
Mepivacaine—Pruritus—Alendronate—osteoporosis	0.00288	0.00288	CcSEcCtD
Mepivacaine—Tinnitus—Estradiol—osteoporosis	0.00287	0.00287	CcSEcCtD
Mepivacaine—Hypersensitivity—Calcitriol—osteoporosis	0.00286	0.00286	CcSEcCtD
Mepivacaine—Asthenia—Ibandronate—osteoporosis	0.00284	0.00284	CcSEcCtD
Mepivacaine—Anxiety—Conjugated Estrogens—osteoporosis	0.00284	0.00284	CcSEcCtD
Mepivacaine—Nausea—Etidronic acid—osteoporosis	0.00284	0.00284	CcSEcCtD
Mepivacaine—Anaphylactic shock—Zoledronate—osteoporosis	0.00283	0.00283	CcSEcCtD
Mepivacaine—Oedema—Zoledronate—osteoporosis	0.00283	0.00283	CcSEcCtD
Mepivacaine—Pruritus—Ibandronate—osteoporosis	0.0028	0.0028	CcSEcCtD
Mepivacaine—Shock—Zoledronate—osteoporosis	0.00279	0.00279	CcSEcCtD
Mepivacaine—Paraesthesia—Pamidronate—osteoporosis	0.00279	0.00279	CcSEcCtD
Mepivacaine—Asthenia—Calcitriol—osteoporosis	0.00278	0.00278	CcSEcCtD
Mepivacaine—Tachycardia—Zoledronate—osteoporosis	0.00277	0.00277	CcSEcCtD
Mepivacaine—Chills—Estradiol—osteoporosis	0.00276	0.00276	CcSEcCtD
Mepivacaine—Somnolence—Pamidronate—osteoporosis	0.00276	0.00276	CcSEcCtD
Mepivacaine—Pruritus—Calcitriol—osteoporosis	0.00274	0.00274	CcSEcCtD
Mepivacaine—Hyperhidrosis—Zoledronate—osteoporosis	0.00274	0.00274	CcSEcCtD
Mepivacaine—Dizziness—Estropipate—osteoporosis	0.00273	0.00273	CcSEcCtD
Mepivacaine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00273	0.00273	CcSEcCtD
Mepivacaine—Oedema—Conjugated Estrogens—osteoporosis	0.00273	0.00273	CcSEcCtD
Mepivacaine—Dizziness—Alendronate—osteoporosis	0.00269	0.00269	CcSEcCtD
Mepivacaine—Shock—Conjugated Estrogens—osteoporosis	0.00269	0.00269	CcSEcCtD
Mepivacaine—Erythema—Estradiol—osteoporosis	0.00268	0.00268	CcSEcCtD
Mepivacaine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00266	0.00266	CcSEcCtD
Mepivacaine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00266	0.00266	CcSEcCtD
Mepivacaine—Hypotension—Zoledronate—osteoporosis	0.00265	0.00265	CcSEcCtD
Mepivacaine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00265	0.00265	CcSEcCtD
Mepivacaine—Dizziness—Raloxifene—osteoporosis	0.00265	0.00265	CcSEcCtD
Mepivacaine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00264	0.00264	CcSEcCtD
Mepivacaine—Tension—Estradiol—osteoporosis	0.00263	0.00263	CcSEcCtD
Mepivacaine—Vomiting—Estropipate—osteoporosis	0.00263	0.00263	CcSEcCtD
Mepivacaine—Dizziness—Ibandronate—osteoporosis	0.00262	0.00262	CcSEcCtD
Mepivacaine—Nervousness—Estradiol—osteoporosis	0.0026	0.0026	CcSEcCtD
Mepivacaine—Urticaria—Risedronate—osteoporosis	0.00259	0.00259	CcSEcCtD
Mepivacaine—Back pain—Estradiol—osteoporosis	0.00259	0.00259	CcSEcCtD
Mepivacaine—Headache—Estropipate—osteoporosis	0.00259	0.00259	CcSEcCtD
Mepivacaine—Vomiting—Alendronate—osteoporosis	0.00259	0.00259	CcSEcCtD
Mepivacaine—Body temperature increased—Risedronate—osteoporosis	0.00258	0.00258	CcSEcCtD
Mepivacaine—Hypotension—Conjugated Estrogens—osteoporosis	0.00255	0.00255	CcSEcCtD
Mepivacaine—Headache—Alendronate—osteoporosis	0.00255	0.00255	CcSEcCtD
Mepivacaine—Paraesthesia—Zoledronate—osteoporosis	0.00255	0.00255	CcSEcCtD
Mepivacaine—Vomiting—Raloxifene—osteoporosis	0.00254	0.00254	CcSEcCtD
Mepivacaine—Somnolence—Zoledronate—osteoporosis	0.00252	0.00252	CcSEcCtD
Mepivacaine—Vomiting—Ibandronate—osteoporosis	0.00252	0.00252	CcSEcCtD
Mepivacaine—Tremor—Estradiol—osteoporosis	0.00251	0.00251	CcSEcCtD
Mepivacaine—Headache—Raloxifene—osteoporosis	0.00251	0.00251	CcSEcCtD
Mepivacaine—Headache—Ibandronate—osteoporosis	0.00248	0.00248	CcSEcCtD
Mepivacaine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00247	0.00247	CcSEcCtD
Mepivacaine—Vomiting—Calcitriol—osteoporosis	0.00247	0.00247	CcSEcCtD
Mepivacaine—Agitation—Estradiol—osteoporosis	0.00246	0.00246	CcSEcCtD
Mepivacaine—Nausea—Estropipate—osteoporosis	0.00245	0.00245	CcSEcCtD
Mepivacaine—Body temperature increased—Pamidronate—osteoporosis	0.00245	0.00245	CcSEcCtD
Mepivacaine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00245	0.00245	CcSEcCtD
Mepivacaine—Angioedema—Estradiol—osteoporosis	0.00245	0.00245	CcSEcCtD
Mepivacaine—Headache—Calcitriol—osteoporosis	0.00243	0.00243	CcSEcCtD
Mepivacaine—Somnolence—Conjugated Estrogens—osteoporosis	0.00243	0.00243	CcSEcCtD
Mepivacaine—Nausea—Alendronate—osteoporosis	0.00242	0.00242	CcSEcCtD
Mepivacaine—Hypersensitivity—Risedronate—osteoporosis	0.0024	0.0024	CcSEcCtD
Mepivacaine—Asthenia—Ethinyl Estradiol—osteoporosis	0.0024	0.0024	CcSEcCtD
Mepivacaine—Syncope—Estradiol—osteoporosis	0.0024	0.0024	CcSEcCtD
Mepivacaine—Nausea—Raloxifene—osteoporosis	0.00238	0.00238	CcSEcCtD
Mepivacaine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00237	0.00237	CcSEcCtD
Mepivacaine—Nausea—Ibandronate—osteoporosis	0.00235	0.00235	CcSEcCtD
Mepivacaine—Loss of consciousness—Estradiol—osteoporosis	0.00235	0.00235	CcSEcCtD
Mepivacaine—Asthenia—Risedronate—osteoporosis	0.00234	0.00234	CcSEcCtD
Mepivacaine—Hypertension—Estradiol—osteoporosis	0.00231	0.00231	CcSEcCtD
Mepivacaine—Pruritus—Risedronate—osteoporosis	0.00231	0.00231	CcSEcCtD
Mepivacaine—Nausea—Calcitriol—osteoporosis	0.0023	0.0023	CcSEcCtD
Mepivacaine—Hypersensitivity—Pamidronate—osteoporosis	0.00229	0.00229	CcSEcCtD
Mepivacaine—Anxiety—Estradiol—osteoporosis	0.00227	0.00227	CcSEcCtD
Mepivacaine—Urticaria—Zoledronate—osteoporosis	0.00225	0.00225	CcSEcCtD
Mepivacaine—Body temperature increased—Zoledronate—osteoporosis	0.00224	0.00224	CcSEcCtD
Mepivacaine—Asthenia—Pamidronate—osteoporosis	0.00223	0.00223	CcSEcCtD
Mepivacaine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00221	0.00221	CcSEcCtD
Mepivacaine—Pruritus—Pamidronate—osteoporosis	0.0022	0.0022	CcSEcCtD
Mepivacaine—Anaphylactic shock—Estradiol—osteoporosis	0.00218	0.00218	CcSEcCtD
Mepivacaine—Oedema—Estradiol—osteoporosis	0.00218	0.00218	CcSEcCtD
Mepivacaine—Urticaria—Conjugated Estrogens—osteoporosis	0.00217	0.00217	CcSEcCtD
Mepivacaine—Dizziness—Risedronate—osteoporosis	0.00216	0.00216	CcSEcCtD
Mepivacaine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00216	0.00216	CcSEcCtD
Mepivacaine—Shock—Estradiol—osteoporosis	0.00215	0.00215	CcSEcCtD
Mepivacaine—Tachycardia—Estradiol—osteoporosis	0.00213	0.00213	CcSEcCtD
Mepivacaine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00213	0.00213	CcSEcCtD
Mepivacaine—Hyperhidrosis—Estradiol—osteoporosis	0.00211	0.00211	CcSEcCtD
Mepivacaine—Headache—Ethinyl Estradiol—osteoporosis	0.0021	0.0021	CcSEcCtD
Mepivacaine—Hypersensitivity—Zoledronate—osteoporosis	0.00209	0.00209	CcSEcCtD
Mepivacaine—Vomiting—Risedronate—osteoporosis	0.00208	0.00208	CcSEcCtD
Mepivacaine—Dizziness—Pamidronate—osteoporosis	0.00205	0.00205	CcSEcCtD
Mepivacaine—Headache—Risedronate—osteoporosis	0.00204	0.00204	CcSEcCtD
Mepivacaine—Asthenia—Zoledronate—osteoporosis	0.00203	0.00203	CcSEcCtD
Mepivacaine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00201	0.00201	CcSEcCtD
Mepivacaine—Pruritus—Zoledronate—osteoporosis	0.00201	0.00201	CcSEcCtD
Mepivacaine—Nausea—Ethinyl Estradiol—osteoporosis	0.00199	0.00199	CcSEcCtD
Mepivacaine—Vomiting—Pamidronate—osteoporosis	0.00197	0.00197	CcSEcCtD
Mepivacaine—Paraesthesia—Estradiol—osteoporosis	0.00196	0.00196	CcSEcCtD
Mepivacaine—Asthenia—Conjugated Estrogens—osteoporosis	0.00196	0.00196	CcSEcCtD
Mepivacaine—Headache—Pamidronate—osteoporosis	0.00194	0.00194	CcSEcCtD
Mepivacaine—Somnolence—Estradiol—osteoporosis	0.00194	0.00194	CcSEcCtD
Mepivacaine—Nausea—Risedronate—osteoporosis	0.00194	0.00194	CcSEcCtD
Mepivacaine—Pruritus—Conjugated Estrogens—osteoporosis	0.00193	0.00193	CcSEcCtD
Mepivacaine—Dizziness—Zoledronate—osteoporosis	0.00187	0.00187	CcSEcCtD
Mepivacaine—Nausea—Pamidronate—osteoporosis	0.00184	0.00184	CcSEcCtD
Mepivacaine—Dizziness—Conjugated Estrogens—osteoporosis	0.0018	0.0018	CcSEcCtD
Mepivacaine—Vomiting—Zoledronate—osteoporosis	0.0018	0.0018	CcSEcCtD
Mepivacaine—Headache—Zoledronate—osteoporosis	0.00178	0.00178	CcSEcCtD
Mepivacaine—Vomiting—Conjugated Estrogens—osteoporosis	0.00174	0.00174	CcSEcCtD
Mepivacaine—Urticaria—Estradiol—osteoporosis	0.00174	0.00174	CcSEcCtD
Mepivacaine—Body temperature increased—Estradiol—osteoporosis	0.00173	0.00173	CcSEcCtD
Mepivacaine—Headache—Conjugated Estrogens—osteoporosis	0.00171	0.00171	CcSEcCtD
Mepivacaine—Nausea—Zoledronate—osteoporosis	0.00168	0.00168	CcSEcCtD
Mepivacaine—Nausea—Conjugated Estrogens—osteoporosis	0.00162	0.00162	CcSEcCtD
Mepivacaine—Hypersensitivity—Estradiol—osteoporosis	0.00161	0.00161	CcSEcCtD
Mepivacaine—Asthenia—Estradiol—osteoporosis	0.00157	0.00157	CcSEcCtD
Mepivacaine—Pruritus—Estradiol—osteoporosis	0.00155	0.00155	CcSEcCtD
Mepivacaine—Dizziness—Estradiol—osteoporosis	0.00144	0.00144	CcSEcCtD
Mepivacaine—Vomiting—Estradiol—osteoporosis	0.00139	0.00139	CcSEcCtD
Mepivacaine—Headache—Estradiol—osteoporosis	0.00137	0.00137	CcSEcCtD
Mepivacaine—Nausea—Estradiol—osteoporosis	0.0013	0.0013	CcSEcCtD
